News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Herbert Loong: Mark Your Calendars! ESMO Virtual Plenary for May 2024
Photo from Herbert Loong/X
May 3, 2024, 04:20

Herbert Loong: Mark Your Calendars! ESMO Virtual Plenary for May 2024

Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong, shared on X/Twitter:

“Mark Your Calendars! ESMO – European Oncology Virtual Plenary for May 2024: Results from randomized study of 6yrs vs. 3yrs of adjuvant imatinib in high risk GISTs presented by Jean-Yves Blay. Expert commentaries by international experts from US/Europe and Asia Pacific. Don’t miss this!”

Image

Source: Herbert Loong/X

adjuvant imatinib cancer ESMO - Eur. Oncology Herbert Loong high risk GISTs May 2024 OncoDaily Oncology University of Hong Kong Virtual Plenary
Special Coverage
Blog
Apr 22, 2025, 13:59
The systemic therapy options available for mCRPC - National Comprehensive Cancer Network
Science
Apr 22, 2025, 13:49
Joshua Brody: How to measure T-cell BYSTANDER tumor killing to prevent antigen escape after cancer immunotherapy
Blog
Apr 22, 2025, 13:34
Sampad Roy: A potential paradigm shift in breast cancer treatment
Blog
Apr 22, 2025, 13:19
IASLC Board of Directors Elections 2025: Spotlight on Undesignated Seat Candidates
Oncolibrary
Apr 22, 2025, 13:02
Trodelvy and Keytruda Achieve Breakthrough Results, Ushering in a New Era for ADCs in Breast Cancer
Radiotherapy
Apr 22, 2025, 12:05
Success Rate and Survival After Stereotactic Radiotherapy
OncoDaily Pulse
Apr 22, 2025, 11:13
New section on OncoDaily - A space that brings all career opportunities into one place
Oncolibrary
Apr 22, 2025, 11:10
DESTINY-Breast09 trial: Enhertu + Pertuzumab Improves PFS in First-Line HER2+ Metastatic Breast Cancer
Blog
Apr 22, 2025, 11:06
How immune cell baselines may predict CD22 therapy outcomes in Pediatric Cancer - NCI Center for Cancer Research
Blog
Apr 22, 2025, 10:57
Register for MASCC25 at the early bird rate - The Multinational Association of Supportive Care in Cancer
Blog
Apr 22, 2025, 10:51
Amol Akhade: Sacituzumab govitecan plus pembrolizumab shows PFS benefit in metastatic TNBC
Blog
Apr 22, 2025, 10:44
Jeff Hunnicutt: Highlands Oncology Group announces a partnership with Agamon Health